PrEPVacc
PrEP Vacc Registration Cohort Get Involved Contact Member's Area
Latest News News by partner In the Media Journal Publications List Research Dissemination News Archive
Partners Organisation and Governance Our Funders FAQs
PrEPVaccRegistration CohortGet Involved News Latest News News by partner In the Media Journal Publications List Research Dissemination News Archive About Partners Organisation and Governance Our Funders FAQs ContactMember's Area
PrEPVacc
An African-led, European-supported HIV prevention project running in four countries in East and Southern Africa from 2018 to 2024

PrEPVacc News

Examining oral pre-exposure prophylaxis (PrEP) literacy among participants in an HIV vaccine trial preparedness cohort study
Examining oral pre-exposure prophylaxis (PrEP) literacy among participants in an HIV vaccine trial preparedness cohort study
SAMRCPrEP Vacc16 January 2023Research
PrEPVacc announces enrolment ‘almost complete’ during World AIDS Day 2022
PrEPVacc announces enrolment ‘almost complete’ during World AIDS Day 2022
PrEP Vacc1 December 2022
Attitudes towards PrEP uptake and adherence explored in Masaka, Uganda
Attitudes towards PrEP uptake and adherence explored in Masaka, Uganda
MRC/UVRI and LSHTM UgandaPrEP Vacc14 September 2022Research
Getty photographer visits PrEPVacc site at Masaka
Getty photographer visits PrEPVacc site at Masaka
MRC/UVRI and LSHTM UgandaPrEP Vacc25 March 2022Media
PrEPVacc featured in December 2021 'Science et Vie' magazine cover story
PrEPVacc featured in December 2021 'Science et Vie' magazine cover story
MRC/UVRI and LSHTM UgandaPrEP Vacc23 December 2021Media
SAMRC PrEPVacc HIV Prevention Vaccine clinical trial in full swing
SAMRC PrEPVacc HIV Prevention Vaccine clinical trial in full swing
SAMRCPrEP Vacc1 December 2021
‘African scientists should lead in developing an Aids jab for Africa’
‘African scientists should lead in developing an Aids jab for Africa’
MRC/UVRI and LSHTM UgandaPrEP Vacc1 December 2021Media
PrEPVacc featured in JIAS articles in Nov 2021
PrEPVacc featured in JIAS articles in Nov 2021
IMPERIAL, INS, MRC CTU at UCL, MRC/UVRI and LSHTM Uganda, MUHAS, NIMR-MMRC, SAMRCPrEP Vacc30 November 2021
Study leaders congratulate PrEPVacc teams on opening all trial sites
Study leaders congratulate PrEPVacc teams on opening all trial sites
IMPERIAL, MRC/UVRI and LSHTM UgandaPrEP Vacc5 October 2021
First enrolments to PrEPVacc clinical trial at SAMRC in Durban
First enrolments to PrEPVacc clinical trial at SAMRC in Durban
SAMRCPrEP Vacc30 September 2021
Activists push for continuity of HIV vaccine research
Activists push for continuity of HIV vaccine research
MRC/UVRI and LSHTM UgandaPrEP Vacc23 September 2021Media
MUHAS enrols its first participants to the PrEPVacc clinical trial
MUHAS enrols its first participants to the PrEPVacc clinical trial
MUHASPrEP Vacc16 September 2021
Mbeya begins enrolment to PrEPVacc clinical trial
Mbeya begins enrolment to PrEPVacc clinical trial
NIMR-MMRC, MRC/UVRI and LSHTM UgandaPrEP Vacc29 July 2021
Deutsche Welle: ‘After COVID, can researchers speed things up for HIV?’
Deutsche Welle: ‘After COVID, can researchers speed things up for HIV?’
IMPERIALPrEP Vacc19 July 2021Media
HIV R4P Virtual: HIV prevalence and incidence among female sex workers participating in a phase IIB HIV vaccine preparedness study in Dar es Salaam,Tanzania
HIV R4P Virtual: HIV prevalence and incidence among female sex workers participating in a phase IIB HIV vaccine preparedness study in Dar es Salaam,Tanzania
MUHASPrEP Vacc3 February 2021Research
HIV R4P Virtual: Community engagement and volunteer recruitment experiences in a HIV vaccine preparedness study in Masaka, Uganda
HIV R4P Virtual: Community engagement and volunteer recruitment experiences in a HIV vaccine preparedness study in Masaka, Uganda
MRC/UVRI and LSHTM UgandaPrEP Vacc2 February 2021Research
HIV R4P Virtual: Changes in risky sexual behaviour among adult men and women in an HIV vaccine preparedness study in south-western Uganda
HIV R4P Virtual: Changes in risky sexual behaviour among adult men and women in an HIV vaccine preparedness study in south-western Uganda
MRC/UVRI and LSHTM UgandaPrEP Vacc29 January 2021Research
HIV R4P Virtual: Recruitment of participants into an HIV vaccine preparedness study: Experiences from Masaka, Uganda
HIV R4P Virtual: Recruitment of participants into an HIV vaccine preparedness study: Experiences from Masaka, Uganda
MRC/UVRI and LSHTM UgandaPrEP Vacc28 January 2021Research
‘Uganda volunteers in phase III of HIV vaccine efficacy trials’ - The East African reports on start of PrEPVacc
‘Uganda volunteers in phase III of HIV vaccine efficacy trials’ - The East African reports on start of PrEPVacc
MRC/UVRI and LSHTM UgandaPrEP Vacc21 December 2020Media
The Guardian reports on the start of PrEPVacc clinical trial
The Guardian reports on the start of PrEPVacc clinical trial
PrEP Vacc18 December 2020Media
Newer Older
03-Yellow_EDCTP.png
flag_yellow_low.jpg
 

This project is part of the EDCTP2 Programme supported by the European Union

 
prepvacc@gmail.com
Hours
Featured
MUHAS Newsletter: HIV vaccines in PrEPVacc trial fail to reduce infections: Results announced at AIDS 2024 conference
MUHAS Newsletter: HIV vaccines in PrEPVacc trial fail to reduce infections: Results announced at AIDS 2024 conference
PrEPVacc Vaccine Trial Results Dissemination to participants in Masaka, Uganda
PrEPVacc Vaccine Trial Results Dissemination to participants in Masaka, Uganda
PrEPVacc meets the media in Masaka
PrEPVacc meets the media in Masaka
PrEPVacc Vaccine Results Dissemination at SAMRC Verulam: A Step Towards Hope
PrEPVacc Vaccine Results Dissemination at SAMRC Verulam: A Step Towards Hope
Joining the studyFAQs Partners of PrEPVacc
PrEPVacc-logo-reverse-rgb.png
 

Contact: prepvacc@gmail.com | Accessibility

© PrEPVacc Investigators 2023 | All rights reserved